This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors.
Clinical trial NCT06074497 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06074497
- Sponsor
- Kangabio AUSTRALIA LTD PTY
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2026-05-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.